Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 0.94
- Piotroski Score 5.00
- Grade Overweight
- Symbol (ELAN)
- Company Elanco Animal Health Incorporated
- Price $14.71
- Changes Percentage (2.69%)
- Change $0.39
- Day Low $14.33
- Day High $15.13
- Year High $18.80
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/05/2024
- Fiscal Year End N/A
- Average Stock Price Target $27.00
- High Stock Price Target $37.00
- Low Stock Price Target $16.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.65
- Trailing P/E Ratio -6.87
- Forward P/E Ratio -6.87
- P/E Growth -6.87
- Net Income $-1,231,000,000
Income Statement
Quarterly
Annual
Latest News of ELAN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Melania Trump "barely" visible in Donald Trump's campaign -- Fox News host
Fox News host Howard Kurtz noted Melania Trump's low profile in her husband's campaign. Analyst Kat Timpf called timing of Melania's memoir release odd. The book, set for October 8, will cover her chi...
By Newsweek | 1 day ago -
How to work freelance, plan ahead and stay afloat in the UK
As a freelancer or sole trader, you must manage trading decisions, self-assessment accounts, and financial organization. Sole traders should keep business and personal finances separate. Register with...
By The Guardian | 1 day ago -
Cleveland Browns at Las Vegas Raiders odds, expert picks, how to watch: Davante Adams, Maxx Crosby out for Raiders
The upcoming Browns vs. Raiders game is evenly matched, with both teams aiming to improve to 2-2. Raiders seek a rebound after a tough loss, facing a struggling Cleveland offense....
By The New York Times | 1 day ago
